Er:YAG laser followed by topical podophyllotoxin for hard-to-treat palmoplantar warts

Journal of Cosmetic and Laser Therapy

Volumn 5, Issue 1, 2003, Pages 35-37

  Wollina, Uwe ^a  

^a ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

Erbium:YAG laser; Palmoplantar warts; Podophyllotoxin; Verrucae vulgares

Indexed keywords

ANTIMITOTIC AGENT; PODOPHYLLOTOXIN; WARTEC;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; ERBIUM YAG LASER; FEMALE; HUMAN; MALE; PIGMENTATION; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; SCAR FORMATION; TREATMENT FAILURE; TREATMENT OUTCOME; VERRUCA VULGARIS; WART VIRUS; WOUND HEALING; WOUND INFECTION;

EID: 0038147505     PISSN: 14764172     EISSN: None     Source Type: Journal    
DOI: 10.1080/14764170310000826     Document Type: Article

References (21)

1. Sterling JC, Handfield-Jones S, Hudson PM. Guidelines for the management of cutaneous warts. Br J Dermatol 2001; 144: 4-11.
2. Berth-Jones J, Bourke J, Eglitis H et al. Value of a second freeze-thaw cycle in cryotherapy of common warts. Br J Dermatol 1994; 131: 883-6.
3. Sloan K, Haberman H, Lynde CW. Carbon dioxide laser treatment of resistant verrucae vulgaris: retrospective analysis. J Cutan Med Surg 1998; 2: 142-5.
4. Sood S, Hruza GJ. Treatment of verruca vulgaris and condyloma acuminatum with lasers. Dermatol Therapy 2000; 13: 90-101.
5. Ross BS, Levine VJ, Nehal K et al. Pulsed dye laser treatment of warts: an update. Dermatol Surg 1999; 25: 377-80.
6. Robson KJ, Gunningham NM, Kruzan KL et al. Pulseddye laser versus conventional therapy in the treatment of warts: a prospective randomized trial. J Am Acad Dermatol 2000; 43: 275-80.
7. Wollina U, Konrad H, Karamfilov T. Treatment of common warts and actinic keratoses by Er:YAG laser. J Cutan Laser Therapy 2001; 3: 63-6.
8. Longstaff E, von Krogh G. Condyloma eradication: self-therapy with 0.15-0.5% podophyllotoxin versus 20-25% podophyllin preparations - an integrated safety assessment. Regul Toxicol Pharmacol 2001; 33: 117-37.
9. Van Krogh G, Lacey CJN, Gross G et al. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect 2000; 76: 162-8.
10. Petzold D, Gross G Diagnostik und Therapie sexuell übertragbarer Krankheiten. Leitlinien 2001 der Deutschen STD-Gesellschaft. Springer: Berlin, Heidelberg, New York, Tokyo, 2001.
11. Kaufmann R, Hartmann A, Hibst R. Cutting and skinablative properties of pulsed mid-infrared laser surgery. J Dermatol Surg Oncol 1994; 20: 112-18.
12. Buckley D. Cryosurgery treatment of plantar warts. Ir Med J 2000; 93: 140-3.
13. Acland KM, Barlow RJ. Lasers for the dermatologist Br J Dermatol 2000; 144: 244-55.
14. 2 and erbium:YAG laser: preoperative, intraoperative, and postoperative considerations. Plast Reconstr Surg 1999; 103: 619-32.
15. Huigol SC, Barlow RJ, Markey AC. Failure of pulsed dye laser therapy for resistant verrucae. Clin Exp Dermatol 1996; 21: 93-5.
16. Langdon RC. Erbium:YAG laser enables compete ablation of periungual verrucae without the need for injected anesthetics. Dermatol Surg 1998; 24: 157-8.
17. Hughes PS, Hughes AP. Absence of human papillomavirus DNA in the plume of erbium:YAG laser-treated warts. J Am Acad Dermatol 1998; 38: 426-8.
18. Webb DG, King SJ. Management of external genital warts: a comparison of podophyllotoxin. Pharmaceut J 1994; 252: 291-3.
19. Strand A, Brinkeborn R-M, Siboulet A. Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution. Genitourin Med 1995; 71: 387-90.
20. Claesson U, Lassus A, Happonen H et al. Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution. Int J STD AIDS 1996; 7: 429-34.
21. Pollock B, Sheehan-Dare R. Pulsed dye laser and intralesional bleomycin for treatment of resistant viral hand warts. Lasers Surg Med 2002; 30: 135-40.